The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role of Signal Transducer and Activator of Transcription 3
Open accessAbstract
Interleukin-22 (IL-22), a recently identified member of the IL-10 family of cytokines that is produced by Th17 and natural killer cells, plays an important role in controlling bacterial infection, homeostasis, and tissue repair. Here, we tested the effect of IL-22 on alcohol-induced liver injury in a murine model of chronic-binge ethanol feeding. Feeding male C57BL/6 mice with a Lieber-DeCarli diet containing 5% ethanol for 10 days, followed by a single dose of ethanol (5 g/kg body weight) by gavage, induces significant fatty liver and liver injury with peak serum levels of approximately 250 IU/L alanine aminotransferase and 420 IU/L aspartate aminotransferase 9 hours after gavage. Moreover, chronic-binge ethanol administration increases expression of hepatic and serum inflammatory cytokines and hepatic oxidative stress. Using this model, we demonstrate that treatment with IL-22 recombinant protein activates hepatic signal transducer and activator of transcription 3 (STAT3) and ameliorates alcoholic fatty liver, liver injury, and hepatic oxidative stress. Administration with IL-22 adenovirus also prevents alcohol-induced steatosis and liver injury. Deletion of STAT3 in hepatocytes abolishes the hepatoprotection provided by IL-22 in alcoholic liver injury. In addition, IL-22 treatment down-regulates the hepatic expression of fatty acid transport protein, but up-regulates several antioxidant, antiapoptotic, and antimicrobial genes. Finally, expression of IL-22 receptor 1 is up-regulated whereas IL-22 is undetectable in the livers from mice with chronic-binge ethanol feeding or patients with alcoholic hepatitis. Conclusion: Chronic-binge ethanol feeding may be a useful model to study the early stages of alcoholic liver injury. IL-22 treatment could be a potential therapeutic option to ameliorate alcoholic liver disease, due to its antioxidant, antiapoptotic, antisteatotic, proliferative, and antimicrobial effects with the added benefit of potentially few side effects. Hepatology 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Shea, R. S., Dasarathy, S., & McCullough, A. J. (2010) · Hepatology · doi:10.1002/hep.23258 · Cited by 1,077
Lucey, M. R., Mathurin, P., & Morgan, T. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0805786 · Cited by 863
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Self-citationNaveau, S., Chollet-Martin, S., Dharancy, S., Mathurin, P., Jouet, P., Piquet, M.-A., Davion, T., Oberti, F., Broët, P., & Emilie, D. (2004) · Hepatology · doi:10.1002/hep.20206 · Cited by 446
Hritz, I., Mandrekar, P., Velayudham, A., Catalano, D., Dolganiuc, A., Kodys, K., Kurt‐Jones, E., & Szabo, G. (2008) · Hepatology · doi:10.1002/hep.22470 · Cited by 415
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., & Diehl, A. M. (1992) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1992.263.4.g579 · Cited by 401
Wolk, K., Witte, E., Witte, K., Warszawska, K., & Sabat, R. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0188-x · Cited by 395
The interleukin-17 pathway is involved in human alcoholic liver disease # †
Lemmers, A., Moreno, C., Gustot, T., Maréchal, R., Degré, D., Demetter, P., de Nadai, P., Geerts, A., Quertinmont, E., Vercruysse, V., et al. (2009) · Hepatology · doi:10.1002/hep.22680 · Cited by 394
Louvet, A., Wartel, F., Castel, H., Dharancy, S., Hollebecque, A., Canva–Delcambre, V., Deltenre, P., & Mathurin, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.062 · Cited by 367
Boetticher, N. C., Peine, C. J., Kwo, P., Abrams, G. A., Patel, T., Aqel, B., Boardman, L., Gores, G. J., Harmsen, W. S., McClain, C. J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.057 · Cited by 340
Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice
Lu, Y., Zhuge, J., Wang, X., Bai, J., & Cederbaum, A. I. (2008) · Hepatology · doi:10.1002/hep.22222 · Cited by 311
Cytokines, STATs and liver disease.
Gao, B. (2005) · PubMed · Cited by 276
Self-citationDifferential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver
Gustot, T., Lemmers, A., Moreno, C., Nagy, N., Quertinmont, E., Nicaise, C., Franchimont, D., Louis, H., Devière, J., & Le Moine, O. (2006) · Hepatology · doi:10.1002/hep.21138 · Cited by 244
Tsukamoto, H., French, S. W., Benson, N., Delgado, G., Rao, A. G., Larkin, E. C., & Largman, C. (1985) · Hepatology · doi:10.1002/hep.1840050212 · Cited by 238
You, M., & Crabb, D. W. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00056.2004 · Cited by 225
Shen, Z., Liang, X., Rogers, C. Q., Rideout, D., & You, M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2009 · Cited by 214
Hong, F., Radaeva, S., Pan, H.-N., Tian, Z., Veech, R., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.1840400424 · Cited by 202
Self-citationHoriguchi, N., Wang, L., Mukhopadhyay, P., Park, O., Jeong, W. I., Lafdil, F., Osei–Hyiaman, D., Moh, A., Fu, X. Y., Pacher, P., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.016 · Cited by 178
Self-citationKang, X., Zhong, W., Liu, J., Song, Z., McClain, C. J., Kang, J. Y., & Zhou, Z. (2009) · Hepatology · doi:10.1002/hep.23090 · Cited by 169
Doege, H., Grimm, D., Falcon, A., Tsang, B., Storm, T. A., Xu, H., Ortegon, A. M., Kazantzis, M., Kay, M. A., & Stahl, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803510200 · Cited by 169
IL-22: A critical mediator in mucosal host defense
Aujla, S. J., & Kolls, J. K. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0448-1 · Cited by 162
Self-citationManagement strategies in alcoholic liver disease
Tilg, H., & Day, C. P. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0683 · Cited by 161
Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22
Yang, L., Zhang, Y., Wang, L., Fan, F., Zhu, L., Li, Z., Ruan, X., Huang, H., Wang, Z., Huang, Z., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.004 · Cited by 159
Comments on Aasld Practice Guidelines for Alcoholic Liver Disease
McCullough, A. J., Dasarathy, S., & O’Shea, R. (2010) · Hepatology · doi:10.1002/hep.23652 · Cited by 149
Metallothionein Protection against Alcoholic Liver Injury through Inhibition of Oxidative Stress
Zhou, Z., Sun, X., & Kang, Y. J. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700310 · Cited by 139
Colmenero, J., Bataller, R. A., Sancho‐Bru, P., Bellot, P., Miquel, R., Moreno, M., Jares, P., Bosch, J., Arroyo, V., Caballería, J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.12.036 · Cited by 124
Self-citationButura, A., Nilsson, K. C., Morgan, K., Morgan, T. R. M., French, S. W., Johansson, I., Schuppe‐Koistinen, I., & Ingelman‐Sundberg, M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.020 · Cited by 115
IL-22 is involved in liver regeneration after hepatectomy
Ren, X., Hu, B., & Colletti, L. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00075.2009 · Cited by 109
Roychowdhury, S., McMullen, M. R., Pritchard, M. T., Hise, A. G., van Rooijen, N., Medof, E. M., Stavitsky, A. B., & Nagy, L. E. (2008) · Hepatology · doi:10.1002/hep.22776 · Cited by 102
Models of Alcoholic Liver Disease in Rodents: A Critical Evaluation
Hall, P. D. L. Μ., Lieber, C. S., DeCarli, L. M., French, S. W., Lindros, K. O., Järveläinen, H. A., Bode, C., Parlesak, A., & Bode, J. C. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02405.x · Cited by 99
“Second Hit” Models of Alcoholic Liver Disease
Tsukamoto, H., Machida, K., Dynnyk, A., & Mkrtchyan, H. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214373 · Cited by 97
Beier, J. I., Luyendyk, J. P., Guo, L., von Montfort, C., Staunton, D. E., & Arteel, G. E. (2009) · Hepatology · doi:10.1002/hep.22847 · Cited by 93
Early-Phase Alcoholic Liver Disease: An Update on Animal Models, Pathology, and Pathogenesis
Ramaiah, S. K., Rivera, C. A., & Arteel, G. E. (2004) · International Journal of Toxicology · doi:10.1080/10915810490502069 · Cited by 85
Esfandiari, F., Medici, V., Wong, D. H., Jose, S., Dolatshahi, M., Quinlivan, E. P., Dayal, S., Lentz, S. R., Tsukamoto, H., Zhang, Y. H., et al. (2009) · Hepatology · doi:10.1002/hep.23382 · Cited by 82
Intragastric Ethanol Infusion Model in Rodents
Tsukamoto, H., Mkrtchyan, H., & Dynnyk, A. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-242-7_3 · Cited by 55
Animal models of alcoholic liver disease--focus on the intragastric feeding model.
Nanji, A. A., & French, S. W. (2003) · PubMed · Cited by 45
Seitz, H. K., & Mueller, S. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_34 · Cited by 45
Models of Alcoholic Liver Disease in Rodents: A Critical Evaluation
Hall, P. D. L. Μ., Lieber, C. S., DeCarli, L. M., French, S. W., Lindros, K. O., inen, H. A. J. R., Bode, C., Parlesak, A., & Bode, J. C. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200105051-00041 · Cited by 42
Recombinant human interleukin-6: safety issues of a pleiotropic growth factor
Kammuller, M. E. (1995) · Toxicology · doi:10.1016/0300-483x(95)03128-3 · Cited by 29
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Self-citationMouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213
Self-citationInterleukin-22: Immunobiology and Pathology
Dudakov, J. A., Hanash, A. M., & van den Brink, M. R. M. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112123 · Cited by 905
Ischaemia–reperfusion injury in liver transplantation—from bench to bedside
Zhai, Y., Petrowsky, H., Hong, J. C., Busuttil, R. W., & Kupiec-Weglinski, J. W. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.225 · Cited by 843
Metadata
- Authors
- Ki, S. H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J. K., Bataller, R., & Gao, B.
- Venue
- Hepatology
- Published
- 2010-10
- Volume
- 52
- Issue
- 4
- Pages
- 1291-1300
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2062564526
- Cited by
- 434
- References
- 39
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.